Cargando…

Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease

Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sucre, Jennifer, Haist, Lena, Bolton, Charlotte E., Hilgendorff, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200413/
https://www.ncbi.nlm.nih.gov/pubmed/34136503
http://dx.doi.org/10.3389/fmed.2021.665152
_version_ 1783707596825296896
author Sucre, Jennifer
Haist, Lena
Bolton, Charlotte E.
Hilgendorff, Anne
author_facet Sucre, Jennifer
Haist, Lena
Bolton, Charlotte E.
Hilgendorff, Anne
author_sort Sucre, Jennifer
collection PubMed
description Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects provoked by these measures include inflammatory processes, oxidative stress, altered growth factor signaling, and remodeling of the extracellular matrix. Both, acute and long-term consequences are determined by the capacity of the immature lung to respond to the challenges outlined above. The subsequent impairment of lung growth translates into an altered trajectory of lung function later in life. Here, knowledge about second and third hit events provoked through environmental insults are of specific importance when advocating lifestyle recommendations to this patient population. A profound exchange between the different health care professionals involved is urgently needed and needs to consider disease origin while future monitoring and treatment strategies are developed.
format Online
Article
Text
id pubmed-8200413
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82004132021-06-15 Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease Sucre, Jennifer Haist, Lena Bolton, Charlotte E. Hilgendorff, Anne Front Med (Lausanne) Medicine Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects provoked by these measures include inflammatory processes, oxidative stress, altered growth factor signaling, and remodeling of the extracellular matrix. Both, acute and long-term consequences are determined by the capacity of the immature lung to respond to the challenges outlined above. The subsequent impairment of lung growth translates into an altered trajectory of lung function later in life. Here, knowledge about second and third hit events provoked through environmental insults are of specific importance when advocating lifestyle recommendations to this patient population. A profound exchange between the different health care professionals involved is urgently needed and needs to consider disease origin while future monitoring and treatment strategies are developed. Frontiers Media S.A. 2021-05-31 /pmc/articles/PMC8200413/ /pubmed/34136503 http://dx.doi.org/10.3389/fmed.2021.665152 Text en Copyright © 2021 Sucre, Haist, Bolton and Hilgendorff. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Sucre, Jennifer
Haist, Lena
Bolton, Charlotte E.
Hilgendorff, Anne
Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title_full Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title_fullStr Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title_full_unstemmed Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title_short Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
title_sort early changes and indicators characterizing lung aging in neonatal chronic lung disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200413/
https://www.ncbi.nlm.nih.gov/pubmed/34136503
http://dx.doi.org/10.3389/fmed.2021.665152
work_keys_str_mv AT sucrejennifer earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease
AT haistlena earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease
AT boltoncharlottee earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease
AT hilgendorffanne earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease